Can you interpret this patient's lipid panel results (total cholesterol 100 mg/dL, triglycerides 30 mg/dL, HDL 43 mg/dL, LDL 51 mg/dL, VLDL 6 mg/dL, cholesterol‑to‑HDL ratio 2.3)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lipid Panel Interpretation: Excellent Overall Profile with One Consideration

This patient's lipid panel is excellent overall, with all major cardiovascular risk markers in optimal ranges—total cholesterol 100 mg/dL, LDL 51 mg/dL, and a favorable cholesterol/HDL ratio of 2.3—but the HDL cholesterol of 43 mg/dL warrants attention as it falls slightly above the lower threshold for increased cardiovascular risk in men (40 mg/dL) yet remains suboptimal.

Individual Component Analysis

Total Cholesterol: 100 mg/dL (Low)

  • This is well below the desirable range of 120-200 mg/dL
  • While the reference range shows this as "low," extremely low total cholesterol is not necessarily concerning when LDL and other components are favorable 1
  • No intervention needed for this isolated finding

LDL Cholesterol: 51 mg/dL (Optimal)

  • This is exceptionally low and far below treatment targets
  • Current guidelines establish LDL <100 mg/dL as optimal for primary prevention 2, 1
  • For very high-risk patients, targets are <70 mg/dL 3
  • At 51 mg/dL, this patient has achieved what would be considered an aggressive secondary prevention target
  • No LDL-lowering therapy is indicated

HDL Cholesterol: 43 mg/dL (Borderline Low)

  • Falls within the reference range (35-85 mg/dL) but is suboptimal
  • European guidelines identify HDL <40 mg/dL in men and <45 mg/dL in women as markers of increased cardiovascular risk 3
  • The 2003 AHA/ACC guidelines note HDL <40 mg/dL as a positive risk factor 2
  • At 43 mg/dL, this is marginally above the high-risk threshold but could benefit from lifestyle optimization

Triglycerides: 30 mg/dL (Optimal)

  • Exceptionally low and well below the upper limit of normal (149 mg/dL)
  • Guidelines consider triglycerides <150 mg/dL as desirable 2, 3, 4
  • This very low level is favorable and requires no intervention

VLDL Cholesterol: 6 mg/dL (Low)

  • Below the reference range (8-39 mg/dL)
  • Calculated as triglycerides/5, this reflects the very low triglyceride level
  • Not clinically concerning in this context

Total Cholesterol/HDL Ratio: 2.3 (Excellent)

  • Well below the reference range of 2.5-4.5, indicating low cardiovascular risk
  • Research demonstrates this ratio is superior to LDL alone for predicting coronary heart disease risk 5, 6
  • A ratio <3 in men is associated with substantially reduced cardiovascular risk 6
  • This is one of the strongest favorable indicators in this panel

Clinical Significance & Risk Assessment

The overall lipid profile indicates very low cardiovascular risk from a lipid standpoint:

  • The non-HDL cholesterol (total cholesterol - HDL = 57 mg/dL) is excellent, far below targets of <130 mg/dL for moderate risk or <100 mg/dL for high risk 3
  • The LDL/HDL ratio would be approximately 1.2, which is exceptionally favorable
  • The combination of very low LDL, low triglycerides, and favorable ratios outweighs the borderline HDL level

Recommendations

Primary Focus: HDL Optimization Through Lifestyle

Since the only suboptimal value is the borderline HDL at 43 mg/dL:

  • Increase physical activity: Minimum 30-60 minutes daily of aerobic exercise (walking, jogging, cycling) 2
  • Weight management: If BMI ≥25 kg/m², weight reduction can raise HDL 2
  • Smoking cessation: If applicable, as smoking lowers HDL 2
  • Moderate alcohol consumption: May modestly increase HDL, though this must be balanced against other health considerations 2
  • Dietary modifications: Increase omega-3 fatty acids, reduce trans fats 2

No Pharmacological Therapy Indicated

  • With LDL at 51 mg/dL, statin therapy is absolutely not needed 1
  • Fibrates or niacin for isolated low HDL are not indicated when LDL is already optimal and triglycerides are low 2, 4
  • The risk-benefit ratio does not support medication for HDL raising in this context

Monitoring

  • Repeat lipid panel in 1-2 years if no cardiovascular risk factors present 4, 1
  • If diabetes, hypertension, or other cardiovascular risk factors exist, annual monitoring is appropriate 4

Important Caveats

Consider secondary causes of low total cholesterol if clinically relevant:

  • Malnutrition, malabsorption, hyperthyroidism, liver disease, or certain medications can lower cholesterol
  • However, the favorable LDL/HDL ratio and low triglycerides suggest this is likely a constitutionally favorable lipid profile rather than pathology

Context matters:

  • If this patient is on statin therapy, the LDL of 51 mg/dL represents excellent treatment response
  • If not on lipid-lowering medication, this represents an inherently favorable lipid metabolism

The slightly low HDL should not overshadow the overwhelmingly positive findings in this lipid panel, which collectively indicate very low cardiovascular risk from a lipid perspective.

Related Questions

Based on my lipid panel (total cholesterol 143 mg/dL, triglycerides 63 mg/dL, HDL 45 mg/dL, LDL 86 mg/dL, VLDL 13 mg/dL, cholesterol/HDL ratio 3.2) and the fact that I am not taking a statin, what treatment or lifestyle recommendations are indicated?
Interpret a lipid panel showing total cholesterol 168 mg/dL, triglycerides 97 mg/dL, HDL‑C 96 mg/dL, and LDL‑C 51 mg/dL and advise on management.
How should a patient with hypercholesterolemia and a lipid panel showing total cholesterol 280 mg/dL, LDL (low-density lipoprotein) 143 mg/dL, HDL (high-density lipoprotein) 117 mg/dL, and triglycerides 100 mg/dL be managed?
For a patient with total cholesterol 240 mg/dL, LDL cholesterol 173 mg/dL, triglycerides 72 mg/dL, HDL cholesterol 54 mg/dL, and VLDL cholesterol 13 mg/dL, what is the recommended treatment plan?
What are the optimal total cholesterol-to-HDL and LDL-to-HDL ratio ranges?
What is the optimal vitamin D repletion strategy and formulation for a patient currently using ergocalciferol 50,000 IU twice weekly for 20 doses and planning to re‑measure serum 25‑hydroxyvitamin D?
What are the causes of mitral valve fibrosis seen as late gadolinium enhancement (LGE) on cardiac MRI?
Is Graves disease an autoimmune disorder?
Which neurotransmitter systems are implicated in bipolar disorder?
What is the recommended treatment for uncomplicated urogenital Chlamydia trachomatis infection?
What is the appropriate workup for a patient with a suspected concussion?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.